Edesa hands Kyorin Japan rights to its phase 3 respiratory antibody
The deal is worth up to $140M plus royalties for paridiprubart, an experimental treatment aimed at acute respiratory distress syndrome.
Trending Now
Robinhood Ventures Fund II brings retail capital to healthcare AI
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
Singapore clinics let an AI watch for referrals nobody ever sent
A safety net built from consultation notes caught missed specialist referrals at…
An AI team of agents grades immunotherapy side effects
A Brigham and Dana-Farber system of cooperating language models caught immune-related adverse…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal…
Undecimal Bio raises $18M to push RNA drugs past the liver
The Cambridge spinout says the hard part of RNA interference was never silencing - it…
Teladoc puts fees at risk in AI-powered virtual care platform relaunch
Teladoc Health launches Teladoc One with 100% fee-at-risk model, using AI and unified data to…
DESKi Secures $6M to Scale AI-Powered Cardiac Ultrasound Tool Across U.S. and Europe
With $6 million in seed funding, the Bordeaux-based startup is launching HeartFocus, an FDA-cleared AI…
AIIMS Delhi hands its breast screening AI to a device maker
India's premier public medical institute has transferred an AI mammography interpretation model to BPL Medical…
AI Offers Promise for Hospital Finances—But Only With Strategy and Structure, Experts Say
While AI holds potential to help hospitals manage financial pressures, its success hinges on foundational…
Four pharma giants pool antibodies to train a developability AI
AbbVie, argenx, Lundbeck and Takeda are contributing proprietary antibody sequences to a shared dataset aimed…
GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out
CareIntellect for Operations forecasts capacity crunches three days ahead and recommends how hospital leaders should…